Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2022 | 1 |
2023 | 1 |
2024 | 1 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
KRASG12C-independent feedback activation of wild-type RAS constrains KRASG12C inhibitor efficacy.
Cell Rep. 2022 Jun 21;39(12):110993. doi: 10.1016/j.celrep.2022.110993.
Cell Rep. 2022.
PMID: 35732135
Free PMC article.
Sotorasib Is a Pan-RASG12C Inhibitor Capable of Driving Clinical Response in NRASG12C Cancers.
Rubinson DA, Tanaka N, Fece de la Cruz F, Kapner KS, Rosenthal MH, Norden BL, Barnes H, Ehnstrom S, Morales-Giron AA, Brais LK, Lemke CT, Aguirre AJ, Corcoran RB.
Rubinson DA, et al.
Cancer Discov. 2024 May 1;14(5):727-736. doi: 10.1158/2159-8290.CD-23-1138.
Cancer Discov. 2024.
PMID: 38236605
Free PMC article.
Item in Clipboard
Truncal Dynamics May Trump: Serial ctDNA to Predict Early Therapeutic Response.
Eluri M, Kopetz S, Parseghian CM.
Eluri M, et al.
Clin Cancer Res. 2023 Jan 17;29(2):302-304. doi: 10.1158/1078-0432.CCR-22-2793.
Clin Cancer Res. 2023.
PMID: 36378102
Free PMC article.
Item in Clipboard
Cite
Cite